BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9293769)

  • 1. Insertion of 2 kb of bacteriophage DNA between an immunoglobulin promoter and leader exon stops somatic hypermutation in a kappa transgene.
    Winter DB; Sattar N; Mai JJ; Gearhart PJ
    Mol Immunol; 1997 Apr; 34(5):359-66. PubMed ID: 9293769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic hypermutation of an artificial test substrate within an Ig kappa transgene.
    Klotz EL; Hackett J; Storb U
    J Immunol; 1998 Jul; 161(2):782-90. PubMed ID: 9670955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
    Tumas-Brundage KM; Vora KA; Manser T
    Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.
    Rogerson BJ
    Mol Immunol; 1994 Feb; 31(2):83-98. PubMed ID: 8309480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5' hypermutation boundary of kappa chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription.
    Rada C; Yélamos J; Dean W; Milstein C
    Eur J Immunol; 1997 Dec; 27(12):3115-20. PubMed ID: 9464795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-associated displacement of hypermutations.
    Wu P; Claflin L
    Int Immunol; 1998 Aug; 10(8):1131-8. PubMed ID: 9723699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
    Rada C; González-Fernández A; Jarvis JM; Milstein C
    Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
    Giusti AM; Manser T
    J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes.
    Umar A; Schweitzer PA; Levy NS; Gearhart JD; Gearhart PJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4902-6. PubMed ID: 1905016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
    Hengstschläger M; Williams M; Maizels N
    Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes.
    Sharpe MJ; Milstein C; Jarvis JM; Neuberger MS
    EMBO J; 1991 Aug; 10(8):2139-45. PubMed ID: 1905999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.
    Weber JS; Berry J; Manser T; Claflin JL
    J Immunol; 1991 May; 146(10):3652-5. PubMed ID: 1902859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.
    Betz AG; Milstein C; González-Fernández A; Pannell R; Larson T; Neuberger MS
    Cell; 1994 Apr; 77(2):239-48. PubMed ID: 8168132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.
    O'Brien RL; Brinster RL; Storb U
    Nature; 1987 Mar 26-Apr 1; 326(6111):405-9. PubMed ID: 3104790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.
    Kong Q; Zhao L; Subbaiah S; Maizels N
    J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.
    Rada C; Milstein C
    EMBO J; 2001 Aug; 20(16):4570-6. PubMed ID: 11500383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strand bias in Ig somatic hypermutation is determined by signal sequence within the variable region.
    Ching AK; Li PS; Chan WY; Ma CH; Lee SS; Lim PL; Chui YL
    Int Immunol; 2000 Sep; 12(9):1245-53. PubMed ID: 10967019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sequences from downstream of the J kappa cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain.
    Klix N; Jolly CJ; Davies SL; Brüggemann M; Williams GT; Neuberger MS
    Eur J Immunol; 1998 Jan; 28(1):317-26. PubMed ID: 9485211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.